 recombin human erythropoietin vascular access incid vascular access clot year first month control period second period month recombin human erythropoietin epoetin averag durat month rang month patient overal incid vascular access monthli rate event patient-month year period distribut number event patient period patient episod patient recurr event episod second period differ incid vascular access epoetin treat patient untreat patient event patient-year event patient-year period event patient-year epoetin vascular access clot